Table 2.
miRNA | Cell types | Potential biomarker | Animal model | miRNA modulation method | Results | Target genes | References |
---|---|---|---|---|---|---|---|
mir-29 | SMC EC FB | No | Elastase, AngII, Marfan | Viral OE Anti-miR |
Inhibition reduces AAA | collagens elastin |
62, 65, 95 |
miR-21 | SMC EC FB |
No | Elastase, AngII | Viral OE Anti-miR |
OE reduces AAA | PTEN | 50 |
miR-24 | SMC EC MPh |
Yes | Elastase, AngII | Viral OE Inhibition |
OE reduces AAA | CHI3L1 | 77 |
miR-33 | SMC MPh HC |
No | AngII, CCl2 | Knockout | Inhibition reduces AAA | ABCA1 | 78,80 |
miR-143 miR-145 |
SMC FB EC | No* | AngII | Viral OE Knockout | OE induces SMC differentiation | KLF4 PHACTR4 | 83 |
miR-181b | MPh EC | No | AngII | Anti-miR | Conflicting results | TIMP3 elastin |
85–87 |
miR-195 | SMC | Yes | AngII | AntagomiR | Inhibition reduces AAA | collagen
proteoglycan elastin SMAD3 |
68, 89–91 |
miR-205 miR-712 |
EC SMC | No | AngII | Anti-miR | Inhibition reduces AAA | TIMP3 | 57 |
SMC: Smooth muscle cells, EC: Endothelial cells, FB: Fibroblasts, MPh: Macrophages, HC: Hepatocytes, AngII: Angiotensin II, OE: Overexpression. *miR-143/145 may be useful biomarkers for vascular disease, but not specific for aneurysms.